Common Reasons for Device Submission Refusal or Denial – global pharmacovigilance Common Reasons for Device Submission Refusal or Denial under FDA Device Approvals In today’s competitive landscape of medical devices and combination products, understanding the nuances of the submission process to the FDA is essential for ensuring successful market entry. Devices can face refusals or denials for a multitude of reasons, which can cause significant delays, increased costs, and decreased competitive advantage. This article provides a detailed step-by-step guide on common reasons behind submission refusals or denials and outlines strategies to enhance your submission’s chances of approval under the current…

FDA Breakthrough Device Designation: Criteria and Benefits – clinical study report writing FDA Breakthrough Device Designation: Criteria and Benefits for Clinical Study Report Writing Introduction to FDA Breakthrough Device Designation The FDA Breakthrough Device Designation (BDD) is a program designed to expedite the development and review of medical devices that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. This tutorial guide aims to walk regulatory affairs professionals through the criteria for receiving Breakthrough Device Designation, the benefits it offers, and its implications for clinical study report writing. The FDA’s intent with the BDD program…

eSTAR and eCopy: FDA’s Digital Submission Tools for Devices – pharmaceutical laws eSTAR and eCopy: FDA’s Digital Submission Tools for Devices The landscape of regulatory submissions for medical devices has evolved significantly with the advent of digital tools. The FDA (U.S. Food and Drug Administration) has introduced eSTAR (electronic Submission Template and Resource) and eCopy (an electronic copy of submissions) as part of its ongoing commitment to facilitating regulatory processes. This comprehensive tutorial will guide you through the understanding and utilization of these digital submission tools, ensuring compliance with pharmaceutical laws and enhancing efficiency in the approval process of medical…

Device Recalls and Market Withdrawals: How FDA Monitors Safety – product compliance consulting Device Recalls and Market Withdrawals: How FDA Monitors Safety Understanding the regulatory landscape for medical devices is paramount for stakeholders in the field of product compliance consulting. With the increasing complexity of medical device technology and the critical nature of patient safety, proper management of device recalls and market withdrawals is essential. This guide provides a comprehensive overview of how the FDA monitors safety through recalls and withdrawals, particularly in relation to regulatory affairs and compliance. 1. Understanding Device Recalls: Definitions and Classifications Device recalls and market…

Medical Device Reporting (MDR) Requirements for Manufacturers – pharmacovigilance solutions Medical Device Reporting (MDR) Requirements for Manufacturers In the dynamic field of medical devices and combination products, understanding the Medical Device Reporting (MDR) requirements is crucial for manufacturers worldwide. These requirements ensure that devices are safe and effective and establish a framework for monitoring post-market performance. This guide offers a comprehensive, step-by-step breakdown of the MDR requirements as set forth by various regulatory bodies, including the FDA, EMA, and others, with a focus on pharmacovigilance solutions that align with regulatory affairs and compliance. 1. Understanding Medical Device Reporting (MDR) Medical…

Tips for Navigating the FDA’s Device Registration and Listing Process – regulatory affairs and compliance Tips for Navigating the FDA’s Device Registration and Listing Process The registration and listing process for medical devices with the FDA is crucial for regulatory affairs and compliance professionals. Navigating this pathway successfully requires a thorough understanding of FDA requirements, from classification to pre-market and post-market surveillance. This guide offers a comprehensive, step-by-step approach aimed at guiding regulatory affairs teams through the complex landscape of medical device registration and listing. Step 1: Understanding the FDA Medical Device Classification The first step in the FDA device…

Human Factors Engineering and FDA Device Usability Expectations – compliance regulatory affairs Human Factors Engineering and FDA Device Usability Expectations Under FDA Device Approvals This article provides a comprehensive step-by-step tutorial on Human Factors Engineering (HFE) and its significance in meeting FDA Device Usability Expectations. It is particularly relevant for stakeholders involved in compliance regulatory affairs in the context of medical devices and combination products. By understanding the relationships between Human Factors Engineering, usability, and regulatory requirements, professionals can navigate the complex landscape of FDA device approvals while ensuring compliance with both domestic and international standards. Understanding Human Factors Engineering…

Preparing for a Pre-Submission Meeting with CDRH – regulatory affairs compliance Preparing for a Pre-Submission Meeting with CDRH: A Comprehensive Step-by-Step Guide for Regulatory Affairs Compliance In the dynamic landscape of medical devices and combination products, preparing for a pre-submission meeting with the Center for Devices and Radiological Health (CDRH) is a critical step in ensuring successful regulatory affairs compliance. This tutorial provides a comprehensive guide aimed at assisting regulatory affairs professionals, quality assurance teams, and market access stakeholders in executing effective pre-submission meetings with the CDRH. The process involves meticulous planning, understanding regulatory pathways, and recognizing the importance of…

Post-Approval Studies and Surveillance for Class III Devices – pharmacovig Post-Approval Studies and Surveillance for Class III Devices Post-approval studies (PAS) and post-market surveillance (PMS) serve crucial roles in ensuring the continued safety and effectiveness of Class III medical devices after they have received approval from regulatory authorities such as the FDA, EMA, and others. This tutorial provides a comprehensive guide for regulatory affairs and quality assurance professionals involved in pharmacovigilance practices related to Class III devices. Understanding Class III Medical Devices Class III medical devices are typically those that pose the highest risk to patients and require premarket approval…

Differences Between Substantial Equivalence and Predicate Devices – iqvia pharmacovigilance Understanding the Differences Between Substantial Equivalence and Predicate Devices The medical device industry faces stringent regulatory requirements to ensure safety and efficacy. One of the crucial concepts in the approval process for new medical devices in the United States is “substantial equivalence.” This tutorial outlines the key differences between substantial equivalence and predicate devices under the FDA device approval framework, specifically for stakeholders interested in iqvia pharmacovigilance systems. We will explore the regulatory pathways, technical documentation needs, and the role of pharmacovigilance systems in this context. 1. Introduction to Substantial…